EphB4 as a Novel Target for the EGFR-Independent Suppressive Effects of Osimertinib on Cell Cycle Progression in Non-Small Cell Lung CancerRen Nanamiya, Hironobu Sasano|International Journal of Molecular Sciences|2021Cited by 14
A Sensitive Monoclonal Antibody B4Mab-7 against EphB4 Was Developed for Breast CancersRen Nanamiya, Yukinari Kato|Preprints.org|2023Cited by 1